Design Oncology Clinical Trials with an Experienced Research Partner

Address the complexities associated with clinical trial design and execution, and accelerate patient access to your new cancer care therapy.

A healthcare provider embracing a patient

Cutting Edge Oncology Clinical Trials

Hear how the ability to offer clinical trials has made a difference in patient care for oncology practices.

Cancer immunotherapy development typically requires targeted patients to participate in clinical trials. 支持的 beta365网站 专业的健康, US Oncology Research is well positioned to help organizations seeking to bring new cancer care therapies to market with clinical trial design, execution and patient identification for these investigational agents.


Learn more about beta365网站 solutions for biopharma and life sciences companies.

Innovative Research Organization

US Oncology Research is an industry-leading research organization comprised of more than 60 community-based centers across the country. The size of our network, combined with proprietary technology platforms and our innovative clinical research solutions, allows us to screen thousands of cancer patients across The US Oncology Network and expedite trial accruals.

20多年来, US Oncology Research has been conducting Phase I-IV clinical trials across many indications, including rare tumor types, and has played a role in the approval of 70 therapies. We have enrolled nearly 70,000 cancer patients to more than 1,700 oncology clinical trials, including more than 2,200 patients into Phase I trials.

US Oncology Research Approach

beta365网站的方法 is simple—a central set of processes executed on behalf of pharmaceutical manufacturers for all participating oncology practices in each study: one budget, 一个合同, one institutional review board, one investigational product distribution center, one technology platform, one regulatory document collection process.

beta365网站的方法, coupled with innovative clinical trial acceleration and patient identification solutions, delivers best-in-class performance across all phases of clinical development.

"Our patients don’t have to leave home. That’s the goal of our practice and US Oncology Research makes that happen."
—Haskell Kirkpatrick M.D., Texas Oncology | US Oncology Research


Connecting patients to the latest therapies 关闭 to home.